ITRE reaches agreement on FP7

The European Parliament's Industry, Research and Energy Committee (ITRE) has adopted, in a second reading, a set of comprise amendments on the Seventh Framework Programme (FP7), which were agreed upon in informal meetings with the Council.

The 39 new amendments deal with issues such as the structure of the European Research Council (ERC) and the proposed Risk Sharing Finance Facility (RSFF).

MEPs agreed on an amendment on renewable and end use energy, which foresees a 'major part' of the budget from FP7's energy theme going to the field, instead of two thirds as proposed by the Parliament in its first reading. According to ITRE, special attention will be devoted to the coordination of issues linked to rational and efficient use of energy in FP7 and in other EU policies.

A compromise was also reached regarding the administrative costs of the ERC, which should now not exceed 5% - MEPs had originally asked for a limit of 3%. On the issue of the Parliament's involvement in the interim evaluation of the ERC, it was agreed to opt for co-decision procedure in case changes in the structure of ERC become necessary.

ITRE also endorsed amendments on the rules of participation for companies, research centres and universities, as well as the RSFF, which is designed to encourage bank lending to research projects. Initially, the Council had planned to allocate €1 billion from the FP7 budget to finance RSFF. However, under the amendment, a lower contribution of €500 million is foreseen until 2010, with the possibility of releasing the additional €500 million after a review.

On the European Institute of Technology (EIT), the committee stressed that no money from FP7 should be used to finance the proposed structure. Only administrative costs directly associated with research projects may be covered.

The amended text will be put to the vote at a Parliament plenary session, due to be held on 29 November, before it is put to the Council on 5 December.

If all goes to plan, the first calls for proposals for FP7 projects could be published by December 2006, with closing dates in March 2007. Following an evaluation period, the first FP7 projects could start as early as the end of 2007 or early 2008

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...